Tag: FDA Section 505A

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (12)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image How Air Pollution Fuels Lung Inflammation: Causes, Risks, and Solutions
recent-post-image Blood Clot in Children: Causes, Symptoms & Treatments
recent-post-image How and Where to Buy Trazodone Online Safely (UK, 2025)
recent-post-image How to Access FDA-Required Medication Guides for Your Prescription Drugs
recent-post-image Reglan (Metoclopramide) vs Alternatives: Pros, Cons & Detailed Comparison

Menu

© 2025. All rights reserved.